⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL285207 | 1.00 | — | — | |
| SCHEMBL2226688 | 1.00 | — | — | |
| SCHEMBL15494036 | 0.92 | — | — | |
| SCHEMBL16565997 | 0.92 | — | — | |
| SCHEMBL997385 | 0.92 | — | — | |
| SCHEMBL25260863 | 0.90 | OPRM1 (0.48) | — | |
| SCHEMBL8604975 | 0.90 | OPRM1 (0.48) | — | |
| SCHEMBL3325909 | 0.90 | OPRM1 (0.48) | — | |
| SCHEMBL3322430 | 0.90 | OPRM1 (0.48) | — | |
| SCHEMBL13494822 | 0.90 | OPRM1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20220218709-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | GILEAD SCIENCES, INC. | 2022-07-14 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| US-20190282576-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | GILEAD SCIENCES, INC. | 2019-09-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| US-10285990-B2 | Toll like receptor modulator compounds | GILEAD SCIENCES, INC. (US) | 2019-05-14 | — | — | US | disclosed |
| US-20170281627-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | GILEAD SCIENCES, INC. | 2017-10-05 | — | — | US | disclosed |
| US-9670205-B2 | Toll like receptor modulator compounds | GILEAD SCIENCES, INC. (US) | 2017-06-06 | — | — | US | disclosed |
| EP-1637158-A2 | Capsular polysaccharide immunomodulator | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2006-03-22 | — | — | EP | disclosed |
| EP-0778780-B1 | CAPSULAR POLYSACCHARIDE IMMUNOMODULATOR | BRIGHAM & WOMENS HOSPITAL (US) | 2005-11-23 | — | — | EP | disclosed |
| US-5700787-A | Capsular polysaccharide immunomodulator | BRIGHAM & WOMEN'S HOSPITAL, INC. (US) | 1997-12-23 | — | — | US | disclosed |
| US-5679654-A | PROTECTING AGAINST ABSCESSES FORMATION ASSOCIATED WITH SURGERY, TRAUMA OR DISEASES | BRIGHAM & WOMEN'S HOSPITAL, INC. (US) | 1997-10-21 | — | — | US | disclosed |
| EP-0778780-A1 | CAPSULAR POLYSACCHARIDE IMMUNOMODULATOR | BRIGHAM & WOMEN'S HOSPITAL, INC. (US) | 1997-06-18 | — | — | EP | disclosed |
| WO-1996007427-A1 | CAPSULAR POLYSACCHARIDE IMMUNOMODULATOR | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 1996-03-14 | — | — | WO | disclosed |